738 results on '"Toniutto, Pierluigi"'
Search Results
102. WED-320 - Real-word experience of long-term albumin treatment in a large cohort of patients with cirrhosis and ascites (Real-Answer study)
103. FRI-550 - ACLF course profiles over screening period in the phase IIb DHELIVER study
104. OS-069 - Prophylaxis of HBV-recurrence after liver transplantation in patients with HCC: risk of HCC recurrence from a large, multicentre retrospective study from Italy
105. The Significance of the Furosemide Test for Predicting Ascites Control by Diuretics in Cirrhotics: A Comparison with Volume Expansion and Octreotide Infusion
106. On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites
107. Qualification of tumour mutational burden by targeted next‐generation sequencing as a biomarker in hepatocellular carcinoma
108. Treatment of genotype-1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsers
109. Vitamin A deficiency is associated with hepatitis C virus chronic infection and with unresponsiveness to interferon-based antiviral therapy
110. Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B
111. Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C
112. Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: The role of AST to the platelet ratio index
113. TLR4 rs4986790 A>G genetic polymorphisms predict liver fibrosis severity in caucasian patients with chronic hepatitis B: 1863
114. Long-term maintenance of SVR in difficult-to-treat HCV genotypes in liver transplant recipients with HCV recurrence: 1743
115. A composite score including BMI liver stiffness and rs738409 PNPLA3 genotype might spare liver biopsies to most NAFLD patients maintaining 95% diagnostic accuracy: 1475
116. TLR4 rs4986790 A>G genetic polymorphisms predicts liver fibrosis severity in caucasian patients with chronic hepatitis C: 1033
117. The interleukin 28B rs12979860 C/T polymorphism and serum cholesterol as predictors of fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases
118. Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients
119. Association between vitamin D receptor genetic polymorphisms and acute cellular rejection in liver-transplanted patients
120. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence
121. IS THE PRIMARY IMMUNOSUPPRESSION DRUG (CYCLOSPORIN A OR TACROLIMUS) PLAYING A ROLE ON THE RESPONSE TO ANTIVIRAL TREATMENT FOR POST-TRANSPLANT HCV RECURRENCE?: MO-023
122. Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C
123. Apolipoprotein E genotypes modulate fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases
124. Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C
125. Risk factors for hepatocellular carcinoma recurrence after liver transplantation
126. Long-term albumin administration is not futile in patients with cirrhosis and uncomplicated ascites not normalizing serum albumin concentration with treatment
127. Optimisation and qualification of tumour mutational burden (TMB) by targeted next-generation sequencing (TNGS) as a clinically applicable biomarker in hepatocellular carcinoma (HCC)
128. COVID-19 in an international European liver transplant recipient cohort
129. Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis
130. Outcomes of Liver Transplant for Adults With Wilson’s Disease
131. Steatosis of the hepatic graft as a risk factor for post-transplant biliary complications
132. Sarcoidosis or foreign-body granulomatous reaction during interferon treatment?
133. Vitamin D and the risk of acute allograft rejection following human liver transplantation
134. Correction: Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER cohort study (PLoS ONE (2017) 12: 2 (e0172159) DOI: 10.1371/journal.pone.0172159)
135. Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial
136. Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy
137. Prevalent use of combined prophylaxis of hepatitis B after liver transplantation in Italy: results of a national survey in a large cohort
138. Influence of angiotensin-converting enzyme I/D gene polymorphism on clinical and histological correlates of chronic hepatitis C
139. Expression of the interferon-inducible proteins MxA and IFI16 in liver allografts
140. Occult hepatitis B virus infection in liver transplant recipients with recurrent hepatitis C: relationship with donor age and fibrosis progression
141. Serum Ferritin as a Predictor of Treatment Outcome in Patients With Chronic Hepatitis C
142. MTHFR C677T Polymorphism and Risk of HCC in Patients With Liver Cirrhosis: Role of Male Gender and Alcohol Consumption
143. Endogenous Interferon-α Concentration and Outcome of Interferon Treatment in Patients with Chronic Hepatitis C
144. Relevance of b-values in evaluating liver fibrosis: A study in healthy and cirrhotic subjects using two single-shot spin-echo echo-planar diffusion-weighted sequences
145. Prevalence and risk factors for delayed adrenal insufficiency after liver transplantation
146. Methylenetetrahydrofolate reductase C677T polymorphism and liver fibrosis progression in patients with recurrent hepatitis C
147. Usefulness of six non-proprietary indirect markers of liver fibrosis in patients with chronic hepatitis C
148. Circulating intercellular adhesion molecule 1 predicts non-specific elevation of α1-fetoprotein
149. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation
150. Reply
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.